WALTHAM, Mass., Oct. 26, 2018 /PRNewswire/ -- Fresenius Medical Care's Renal Therapies Group today announced the results of four studies utilizing the Crit-Line ® monitor that examine how relative ...
Please provide your email address to receive an email when new articles are posted on . Blood volume monitoring-guided hemodialysis decreased hospital stay by 2 days. Patients treated with the therapy ...
WALTHAM, Mass., July 27, 2022 /PRNewswire/ -- Fresenius Medical Care North America's (FMCNA) Renal Therapies Group today announced the availability of the CombiSet SMARTECHTM, the first available ...